Addus HomeCare (NASDAQ:ADUS – Get Free Report)‘s stock had its “outperform” rating reiterated by investment analysts at Macquarie in a research report issued on Thursday,Benzinga reports. They presently have a $129.00 price target on the stock. Macquarie’s price target indicates a potential upside of 33.47% from the stock’s current price.
Several other research analysts have also weighed in on the company. Citizens Jmp upgraded Addus HomeCare to a “strong-buy” rating in a report on Monday, December 16th. Stephens dropped their price target on shares of Addus HomeCare from $153.00 to $142.00 and set an “overweight” rating on the stock in a research report on Wednesday. StockNews.com lowered shares of Addus HomeCare from a “buy” rating to a “hold” rating in a research note on Wednesday. JMP Securities assumed coverage on shares of Addus HomeCare in a report on Monday, December 16th. They issued an “outperform” rating and a $150.00 target price on the stock. Finally, Oppenheimer increased their price target on Addus HomeCare from $145.00 to $150.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. One investment analyst has rated the stock with a sell rating, one has given a hold rating, seven have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $132.78.
Check Out Our Latest Report on Addus HomeCare
Addus HomeCare Stock Up 1.0 %
Addus HomeCare (NASDAQ:ADUS – Get Free Report) last issued its quarterly earnings data on Monday, February 24th. The company reported $1.26 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.35 by ($0.09). The firm had revenue of $297.14 million for the quarter, compared to analyst estimates of $291.04 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. As a group, analysts forecast that Addus HomeCare will post 4.59 EPS for the current year.
Insider Buying and Selling
In other Addus HomeCare news, CEO R Dirk Allison sold 25,000 shares of the firm’s stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $124.76, for a total value of $3,119,000.00. Following the sale, the chief executive officer now owns 79,397 shares of the company’s stock, valued at $9,905,569.72. This trade represents a 23.95 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Roberton James Stevenson sold 2,250 shares of the company’s stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $121.00, for a total transaction of $272,250.00. Following the transaction, the executive vice president now directly owns 10,217 shares of the company’s stock, valued at approximately $1,236,257. This trade represents a 18.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 4.60% of the stock is currently owned by insiders.
Institutional Inflows and Outflows
A number of hedge funds have recently bought and sold shares of the business. Connor Clark & Lunn Investment Management Ltd. bought a new stake in shares of Addus HomeCare in the 3rd quarter worth approximately $1,622,000. JPMorgan Chase & Co. boosted its holdings in shares of Addus HomeCare by 10.2% in the third quarter. JPMorgan Chase & Co. now owns 183,198 shares of the company’s stock worth $24,371,000 after buying an additional 16,997 shares during the last quarter. Harbor Capital Advisors Inc. raised its stake in Addus HomeCare by 127.7% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 64,311 shares of the company’s stock worth $8,555,000 after acquiring an additional 36,071 shares during the period. Principal Financial Group Inc. grew its position in shares of Addus HomeCare by 17.5% during the third quarter. Principal Financial Group Inc. now owns 505,853 shares of the company’s stock worth $67,293,000 after purchasing an additional 75,409 shares in the last quarter. Finally, Victory Capital Management Inc. lifted its position in shares of Addus HomeCare by 6.1% in the third quarter. Victory Capital Management Inc. now owns 84,960 shares of the company’s stock worth $11,302,000 after buying an additional 4,913 shares in the last quarter. Hedge funds and other institutional investors own 95.35% of the company’s stock.
About Addus HomeCare
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Recommended Stories
- Five stocks we like better than Addus HomeCare
- When to Sell a Stock for Profit or Loss
- 2 Catalysts That Could Push NVIDIA Stock Up 30% This Year
- Technology Stocks Explained: Here’s What to Know About Tech
- Do GM Stock Buybacks Make the Stock Buyable For Investors?
- CD Calculator: Certificate of Deposit Calculator
- Will Alibaba’s $53B AI Bet Be the Key to Tech Supremacy?
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.